Cryo-electron microscopy (Cryo-EM) and drug design
Our research program is focused on exploring frontiers in structural biology and drug design using cryo electron microscopy (cryo-EM), with the central goal of accelerating the development of effective therapeutic agents. The program is guided by two overarching themes:
Drug Design

A highly focused team effort to use high-resolution cryo-EM imaging of native protein complexes to design effective therapeutic agents targeting cancer, infectious diseases and brain disorders.
Technology Development

An interdisciplinary approach towards developing next generation technologies in cryo-EM using state-of-the-art AI tools and automated workflows coupled with advanced image processing and machine learning.
News
-
UBC researchers studied the case of a B.C. teen critically ill from avian flu. They were surprised
Vancouver Sun [October 02, 2026] In a study published this week in Nature Communications, UBC researchers analyzed two mutations from the B.C. case and found they actually weakened the virus’s ability to bind to human cells.
-
Mutations From Canada’s First Human H5N1 Case Weakened the Virus’s Grip on Cells, UBC Study Finds
Nature World News [September 30, 2026] Two genetic mutations that alarmed scientists after a British Columbia teenager became critically ill with H5N1 bird flu in November 2024 appear to have weakened the virus’s ability to attach to human cells, not strengthened it. Researchers at the University of British Columbia reported the finding on September 28…
-
Study challenges original theory about Canada’s first human case of bird flu
The Globe and Mail [September 28, 2026] University of British Columbia researchers say the unusual genetic mutations identified in Canada’s first human avian influenza case weakened the virus’ ability to bind to human cells, a critical first step in infection.








